3.0.0 8467 2023-01-11T13:44:51Z 2023-01-11T13:44:51Z House HR 2020-09-30 116 [Congressional Record Volume 166, Number 170 (Wednesday, September 30, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. THOMPSON of California:H.R. 8467.Congress has the power to enact this legislation pursuantto the following:Article I[Page H5106]]]> hswm00 Ways and Means Committee House Standing Referred to 2020-09-30T13:01:50Z hsif00 Energy and Commerce Committee House Standing Referred to 2020-09-30T13:01:45Z 2020-09-30 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2020-09-30 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-09-30 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-09-30 Introduced in House IntroReferral 1000 9 Library of Congress T000460 Rep. Thompson, Mike [D-CA-5] MIKE THOMPSON D CA 5 N K000376 Rep. Kelly, Mike [R-PA-16] Mike Kelly R PA 16 2020-09-30 True Health Drug therapy Employee benefits and pensions Health care costs and insurance Health care coverage and access Insurance industry and regulation Medicaid Medicare Prescription drugs Health 00 2020-09-30 Introduced in House 2020-11-06T17:19:43Z Access to Rare Indications Act of 2020

This bill prohibits coverage exclusions or limitations under the Medicare prescription drug benefit, Medicaid, or private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals and that are supported by the National Institutes of Health Rare Diseases Clinical Research Network).

]]> Access to Rare Indications Act of 2020 Display Title Access to Rare Indications Act of 2020 Short Title(s) as Introduced Access to Rare Indications Act of 2020 Introduced in House IH Official Title as Introduced To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to provide for coverage of certain drugs used in the treatment or management of a rare disease or condition, and for other purposes. Introduced in House IH Introduced in House 2020-09-30T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr8467ih/xml/BILLS-116hr8467ih.xml 2020-09-30 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.